Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

IRD — Opus Genetics, Inc. Dilution Risk Tracker

Track IRD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IRD — Get alerts when the score changes →

As of October 13, 2026, Opus Genetics, Inc. (IRD) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Opus Genetics, Inc. has a market capitalization of $386.03M, 83.20M shares outstanding, 79 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $25.00M, 19.62M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
10
📊 Float Risk
70
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 29%
📜 Warrant Exercise model 40%
• Significant warrants: 24% of shares outstanding
• Elevated warrant risk score (70/100)
💰 Capital Raise model 20%
• Active shelf registration ($25M, 6% of market cap)
🔄 Reverse Split model est. 15%
• 52-week low $0.90 has breached $1
🔔 Track IRD — Get forecast alerts →

Market Data

Market Cap$386.03M
Shares Outstanding83.20M
Float34.48M
Cash$88.81M
Debt$1.20M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding83.20MVerified float table or market cache
Public Float34.48MVerified float table or market cache
Market Cap$386.03MMarket data cache
Cash Runway34.3 monthsDilutionWatch score inputs
Shelf Capacity$25.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants19.62MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: FORM 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 87.4% shares (2026Q1 vs prior)
79 institutional holders · 52.36M shares
#1 Caligan Partners LP 6.08M shares
#2 ADAGE CAPITAL PARTNERS GP, L.L.C. 6.03M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 4.90M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest13.01M
Days to Cover6.0
% of Float37.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-06
xbrl XBRL CONVERTIBLE 2026-03-12
Form 4 INSIDER TRANSACTION 2026-09-09
Form 4 INSIDER TRANSACTION 2026-09-09
Form 4 INSIDER TRANSACTION 2026-09-08
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual IRD Dilution Snapshot

Opus Genetics, Inc. (IRD) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

IRD's DilutionScore is currently 65/100 (High risk), with 4 score changes tracked over 89 days. The score improved from 58/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202665/100HIGH16 days
Aug 22 – Sep 27, 202658/100HIGH37 days
Aug 14 – Aug 21, 202667/100HIGH7 days
Jul 17 – Aug 13, 202662/100HIGH28 days
Jul 16, 202661/100HIGH1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

IRD shares outstanding have increased 18.0% from 68.96M (Mar 2026) to 81.40M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 202681.40M34.48M▲ 0.36%
May 01, 202671.40M34.36M▼ 1.69%
Apr 27, 202671.40M34.95M▲ 0.37%
Apr 07, 202671.15M34.82M▼ 0.24%
Mar 17, 202669.89M34.91M▲ 1.90%
Mar 16, 202668.96M34.26M▲ 1.79%
Mar 14, 202668.96M33.65M▲ 1.48%
Mar 13, 202668.96M33.16M▲ 1.57%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track IRD Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment IRD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking IRD — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IRD
IRD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.